当前位置:首页 - 行情中心 - 海昇药业(920656) - 财务分析

海昇药业

(920656)

  

流通市值:5.26亿  总市值:16.25亿
流通股本:3237.63万   总股本:1.00亿

海昇药业(920656)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.20亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益72377.99万元,未分配利润24932.19万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产75038.76万元,负债2660.77万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入65,642,203.39220,598,316.5163,844,572.3100,845,726.94
营业总成本44,276,393.9149,016,474.19111,159,132.0368,348,075.9
其他经营收益
营业利润23,218,504.7480,169,930.1856,662,633.7234,964,001.47
利润总额23,218,504.7480,188,501.4456,681,204.9834,983,551.47
净利润20,092,479.9669,456,983.5249,047,356.730,325,906.98
每股收益
其他综合收益----
综合收益总额20,092,479.9669,456,983.5249,047,356.730,325,906.98
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计520,939,008.84503,791,918.57488,806,422.01485,764,554.08
非流动资产:
非流动资产合计229,448,568.79233,084,127.39216,906,334.3204,564,971.51
资产总计750,387,577.63736,876,045.96705,712,756.31690,329,525.59
流动负债:
流动负债合计21,330,079.8827,976,325.9917,232,710.1426,496,923.39
非流动负债:
非流动负债合计5,277,618.235,455,173.455,781,310.25196,550.56
负债合计26,607,698.1133,431,499.4423,014,020.3926,693,473.95
所有者权益(或股东权益):
归属于母公司股东权益合计723,779,879.52703,444,546.52682,698,735.92663,636,051.64
股东权益合计723,779,879.52703,444,546.52682,698,735.92663,636,051.64
负债和股东权益合计750,387,577.63736,876,045.96705,712,756.31690,329,525.59
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计35,462,235.82147,249,579.7799,635,395.4148,679,002.7
经营活动现金流出小计30,977,133.2111,920,876.8780,705,498.5452,160,096.27
经营活动产生的现金流量净额4,485,102.6235,328,702.918,929,896.87-3,481,093.57
投资活动产生的现金流量:
投资活动现金流入小计1,002,062,125.752,521,984,077.421,834,111,195.971,638,713,798.71
投资活动现金流出小计950,372,837.372,582,952,404.72,202,265,115.091,798,164,144.72
投资活动产生的现金流量净额51,689,288.38-60,968,327.28-368,153,919.12-159,450,346.01
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计-39,698,10039,698,10029,798,100
筹资活动产生的现金流量净额--39,698,100-39,698,100-29,798,100
汇率变动对现金及现金等价物的影响-732,110.49-696,089.16-36,256.69104,897.98
现金及现金等价物净增加额55,442,280.51-66,033,813.54-388,958,378.94-192,624,641.6
期末现金及现金等价物余额436,052,547.46380,610,266.9557,685,701.55254,019,438.89
补充资料:
现金及现金等价物的净增加额--66,033,813.54--192,624,641.6
TOP↑